On Target Laboratories
PrivateLast Round
Series C
Nov 16, 2023
Total Funding Raised
$162.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
On Target Laboratories is a biotechnology company that develops targeted intraoperative molecular imaging agents to illuminate cancer during surgical procedures.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
On Target Laboratories Comparables
Compare On Target Laboratories with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lumicell, Inc. | 87% | |
| Blaze Bioscience, Inc. | 86% | |
| Vergent Bioscience | 81% |
On Target Laboratories Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 16, 2023 | ||||
| Series B Extension | Mar 24, 2021 | ||||
| Series B Extension | Mar 14, 2018 | ||||
| Series B | Nov 2, 2017 | ||||
| Series B | Sep 1, 2017 | ||||
Follow-on Offering | May 1, 2015 |
Key People
Founding team and executive leadership
On Target Laboratories Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Olympus Innovation Ventures | Series C |
| Orion Capital Asia | Series C |
| Elevate Ventures | Series B, Series C, Series B Extension |
| 3B FUTURE Health Fund | Series C, Series B Extension |
| HIG BioHealth Partners | Series B, Series B Extension |
| Pension Fund of the Christian Church | Follow-on Offering, Early Funding, Series C |
| Johnson & Johnson Innovation – JJDC | Series B Extension, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Named to Fast Company's Most Innovative Companies list.
- Feb 11, 2026
Product used in approximately 1,500 commercial procedures to date.
On Target Laboratories Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about On Target Laboratories's valuation, stock price, and market status.
Is On Target Laboratories a public or private company?
On Target Laboratories is a private company.
What is the current stock price of On Target Laboratories?
On Target Laboratories is a private company with no public stock price. No recent secondary market data is available.
How much is On Target Laboratories worth (valuation)?
Valuation information for On Target Laboratories is not publicly available.
Can I buy On Target Laboratories stock?
On Target Laboratories shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was On Target Laboratories's last funding round?
On Target Laboratories's most recent funding round was Series C on November 16, 2023.
Who are the main investors in On Target Laboratories?
Key investors in On Target Laboratories include Elevate Ventures, 3B FUTURE Health Fund, HIG BioHealth Partners, Johnson & Johnson Innovation - JJDC, Inc., The Hurvis Group.
Will On Target Laboratories IPO soon?
No public IPO plans have been announced for On Target Laboratories.
How can I track On Target Laboratories secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor On Target Laboratories's secondary market activity and sign up for updates.